# Glecaprevir/Pibrentasvir for the Treatment of PTSD

> **NCT05446857** · PHASE2,PHASE3 · COMPLETED · sponsor: **White River Junction Veterans Affairs Medical Center** · enrollment: 10 (actual)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** Glecaprevir / Pibrentasvir Pill

## Key facts

- **NCT ID:** NCT05446857
- **Lead sponsor:** White River Junction Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446857, "Glecaprevir/Pibrentasvir for the Treatment of PTSD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05446857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*